Efficacy and safety of bivalirudin in patients receiving clopidogrel therapy after diagnostic angiography for percutaneous coronary intervention in acute coronary syndromes Academic Article uri icon

Overview

MeSH Major

  • Acute Coronary Syndrome
  • Angioplasty, Balloon, Coronary
  • Antithrombins
  • Coronary Angiography
  • Hirudins
  • Peptide Fragments
  • Platelet Aggregation Inhibitors
  • Ticlopidine

abstract

  • In patients presenting with ACS and receiving clopidogrel treatment after angiography (before or within 30 min of PCI), peri-procedural bivalirudin monotherapy suppresses acute and long-term adverse events to a similar extent as does UFH plus GP IIb/IIIa inhibitors, while significantly lowering the risk of bleeding complications.

publication date

  • October 2010

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1002/ccd.22546

PubMed ID

  • 20882655

Additional Document Info

start page

  • 513

end page

  • 24

volume

  • 76

number

  • 4